BioCryst Pharmaceuticals Inc (NASDAQ:BCRX)

4.96
Delayed Data
As of Feb 16
 +0.09 / +1.85%
Today’s Change
3.95
Today|||52-Week Range
9.25
+1.02%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
AssetsCash21.3M54.7M30.5M23.7M
 
 
 
 
 
Short Term Investment Cash273.0K33.4M-25.6M-6.9M
 
 
 
 
 
Cash & Short Term Investments38.2M72.9M53.2M56.2M
 
 
 
 
 
 
ReceivablesReceivables2.1M9.5M6.2M8.8M
 
 
 
 
 
 
InventoriesInventories0.00683.0K1.6M500.0K
 
 
 
 
 
Current AssetsOther Current Assets1.7M6.2M4.9M1.4M
 
 
 
 
 
Current Assets42.0M89.3M65.9M66.9M
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross14.4M14.2M19.4M14.8M
 
 
 
 
 
Depreciation-14.1M-14.0M-14.2M-4.9M
 
 
 
 
 
Other Assets3.9M6.3M5.8M4.1M
 
 
 
 
 
Total Assets48.9M136.9M124.6M89.8M
 
 
 
 
 
 
LiabilitiesAccounts Payable4.2M2.8M9.3M4.3M
 
 
 
 
 
Short Term Debt0.0030.0M30.0M28.2M
 
 
 
 
Accrued Expenses5.7M9.5M15.7M10.4M
 
 
 
 
 
Other Current Liabilities11.1M22.7M24.7M21.4M
 
 
 
 
 
Other Liabilities15.3M57.7M64.5M54.4M
 
 
 
 
 
 
Total LiabilitiesLong Term Debt30.0M0.002.4M25.5M
 
 
 
 
Other Liabilities0.000.00329.0K244.0K
 
 
 
Total Liabilities50.0M61.2M76.8M88.3M
 
 
 
 
 
 
EquityMinority Interest0.000.000.000.00--
Preferred Stock0.000.000.000.00--
Common Equity-1.1M75.6M47.7M1.6M
 
 
 
 
 
Total Shareholder Equity-1.1M75.6M47.7M1.6M
 
 
 
 
 
 
Share InformationCommon Shares Outstanding59.1M72.0M73.4M73.8M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.